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SUMMARY
Insulin resistance (IR) is a complex trait with multiple
genetic and environmental components. Confounded
by large differences between the sexes, environment,
and disease pathology, the genetic basis of IR has
been difficult to dissect. Here we examine IR and
related traits in a diverse population of more than
100 unique male and female inbred mouse strains af-
ter feeding a diet rich in fat and refinedcarbohydrates.
Our results show dramatic variation in IR among
strains of mice and widespread differences between
sexes that are dependent on genotype. We uncover
more than 15 genome-wide significant loci and vali-
date a gene, Agpat5, associated with IR. We also in-
tegrate plasma metabolite levels and global gene
expression from liver and adipose tissue to identify
metabolite quantitative trait loci (mQTL) and expres-
sion QTL (eQTL), respectively. Our results provide a
resource for analysis of interactions between diet,
sex, and genetic background in IR.
INTRODUCTION
Insulin resistance (IR) is characterized by the failure of tissues to
respond appropriately to insulin. Driven by overconsumption of
foods rich in fat and refined carbohydrates throughout the world
and increasing rates of obesity, IR has become a serious global
health problem. IR is an important contributing factor in type 2
diabetes (T2D) and other diseases, including coronary artery dis-
ease and fatty liver disease (Bugianesi et al., 2005; Howard et al.,
1996). Decades of biochemical and physiological studies have
revealed diverse biological mechanisms that contribute to IR
ranging from inflammation and ER stress to aberrant lipid meta-
bolism and gut microbiota dysbiosis (Johnson and Olefsky,
2013). While there have been significant advances in our under-
standing of the pathophysiology of IR, how genetic and environ-
mental factors along with sex differences interact in IR remains
poorly understood.
Genetic studies in humans have been successful at identifying
genetic loci associated with T2D and other related traits, in-
cluding obesity and plasma lipid levels (Grant et al., 2006; Scott
et al., 2012; Sladek et al., 2007; Speliotes et al., 2010; Teslovich
et al., 2010). Despite the successes of genome-wide association
studies (GWASs) for T2D, there has been limited success in iden-
tifying genetic loci associated with IR in non-diabetic popula-
tions. One large GWAS including more than 40,000 non-diabetic
individuals identified only two genome-wide significant loci
associated with homeostatic model assessment of IR (HOMA-
IR) (Dupuis et al., 2010). Recent meta-analyses of glycemic
indices in more than 100,000 individuals have expanded this
number to 19 loci; however, these loci explain only a few percent
of the trait variation (Scott et al., 2012).
In humans, males and females differ dramatically in susce-
ptibility to IR, whereby males are more prone to develop IR
than females (Geer and Shen, 2009). Sex-specific distributions
between visceral and subcutaneous adipose tissue depots as
well as gonadal hormones are believed to be responsible in
part for the dramatic sex differences in IR (Shi et al., 2009).
Experimentally, females are less susceptible to fatty acid-
induced peripheral IR and have increased insulin sensitivity in
adipose tissue (Frias et al., 2001; Macotela et al., 2009).
Targeted biochemical studies have even demonstrated that
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metabolic hormones, such as leptin, have distinct biological
actions between males and females (Shi et al., 2008). Clearly,
complex biological mechanisms contribute to sex differences
in IR, and our understanding of how genetic variation contrib-
utes to these differences between males and females in IR is
limited.
Given the limitations of human studies to identify genetic and
environmental interactions associated with IR, we sought to uti-
lize a systems genetics approach (Civelek and Lusis, 2014) using
a renewable mouse population to explore genetic, sex, and diet
interactions contributing to IR. We examined IR traits in a popu-
lation of 100 common inbred strains of mice, termed the Hybrid
Mouse Diversity Panel (HMDP), which is capable of high-resolu-
tion genome-wide mapping (most loci less than 1 Mb) and sys-
tems-level analysis (Bennett et al., 2010; Farber et al., 2011;
Orozco et al., 2012; Parks et al., 2013). We fed HMDP mouse
strains a high-fat, high-sucrose (HF/HS) diet and assessed IR
and related traits, including central obesity and plasma triglycer-
ide levels. Our results reveal strong relationships between IR and
central obesity, similar to observations in human populations
(Ritchie and Connell, 2007). Our GWAS analyses identify 15
genome-wide significant loci associated with IR and related
traits. Many loci are sex-specific, suggesting that unique genetic
variants contribute to IR amongmales and females.We also inte-
grate plasma metabolite profiles and global gene expression
from liver and adipose to identify metabolite quantitative trait
loci (mQTL) and expression QTL (eQTL), respectively. Our results
provide a resource to identify and interrogate gene-trait, gene-
metabolite, and gene-gene interactions, as well as identify
molecular mediators of IR. We demonstrate the utility of the
resource by identifying multiple high-confidence candidate
genes and validating a gene associated with the development
of IR.
RESULTS
Genetic Variation in IR and Related Traits
A key environmental risk factor driving the development of IR in
humans throughout the world is increased consumption of foods
rich in fat and refined carbohydrates (Malik et al., 2010). To
model this environmental condition in mice we fed more than
100 inbred strains of male and female mice (complete list of
strains and numbers in Table S1) a HF/HS diet (32% kcal from
fat and 25% kcal from sucrose) for 8 weeks and measured key
IR traits, including plasma insulin, plasma glucose, central
obesity, and plasma triglyceride levels. To determine relative IR
across the population we calculated HOMA-IR (Berglund et al.,
2008). After 8 weeks of HF/HS feeding we observed a 63-fold
variation in HOMA-IR among male mice and a 37-fold variation
among female mice (Figure 1A). For almost all strains of mice,
HOMA-IR was higher in males versus their female counter-
parts (Figure 1A). Moreover, HF/HS feeding was important in
increasing HOMA-IR when compared to age-matched chow-
fed mice in both males and females (Figures 2D and 2E).
Along with large variations in HOMA-IR, plasma insulin levels
varied from 270 to 9,200 pg/ml in male mice and from 210 to
5,900 pg/ml in female mice (Figure S1A). Plasma glucose levels
varied from 150 to 500 mg/dl in male mice and from 140 to
420 mg/dl in female mice (Figure S1B).
In humans, IR is often associated with obesity and particu-
larly adipose accumulation within the visceral cavity, com-
monly referred to as central obesity (Johnson and Olefsky,
2013). To test this relationship in our mouse population we
measured total body fat percentage and three unique fat de-
pots within the visceral cavity in each mouse included in the
study. Total body fat percentage exhibited a significant corre-
lation with HOMA-IR in both male mice (r = 0.39; p = 1.97 3
1022) and female mice (r = 0.51; p = 1.77 3 1030) (Figures
1B and 1F). Within the visceral body cavity we dissected and
weighed the mesenteric fat, gonadal fat, and retroperitoneal
fat depots. In the mouse, the mesenteric fat pad is the most
comparable to central obesity humans (Catalano et al., 2010).
In male strains of mice mesenteric fat mass varied from 0.1 g
to 1.6 g and in females from 0.1 g to 2.0 g (Figure S2A). For
males the mesenteric fat pad showed the strongest correlation
with HOMA-IR (r = 0.45; p = 7.86 3 1030) (Figure 1C). Other fat
depots within the visceral cavity, including the gonadal and
retroperitoneal fat depots, exhibited a modest correlation with
HOMA-IR in male mice (Figures 1D and 1E). In contrast to
males, all three adipose depots within the viscera were strongly
correlated with HOMA-IR in female mice (Figures 1G–1I). Over-
all, our data demonstrate large variation in IR among males
and females and a striking gender difference between males
and females that is dependent on genetic background (Fig-
ure 1A). Similar to observations in human populations we
observed a strong correlation between IR and central obesity
(mesenteric fat mass) in both males and females (Figures 1C
and 1G).
Metabolic Characterization of Strains Exhibiting
Differences in HOMA-IR
Our HOMA-IR findings suggest profound variation in the devel-
opment of IR among inbred strains of mice after consuming a
HF/HS diet. To validate these findings we performed euglyce-
mic-hyperinsulinemic clamp studies on the prototypical labora-
tory mouse strain, C57BL/6J, as well as two strains of mice
with large differences in HOMA-IR: A/J and DBA/2J. The A/J,
C57BL/6J, and DBA/2J strains of mice have average HOMA-IR
values of 19, 47, and 113, respectively (Figure 1A). Consistent
with our HOMA-IR findings the rate of exogenous glucose infu-
sion (GIR) required to maintain euglycemia during euglycemic-
hyperinsulinemic clamp studies was significantly reduced in
DBA/2J mice, by 56% (p = 0.013) compared to A/J mice,
whereas C57BL/6J mice showed an intermediate GIR (Fig-
ure 2A). Insulin-stimulated glucose disposal rate (IS-GDR), which
primarily reflects skeletal muscle insulin sensitivity, was reduced
by 50% (p = 0.02) in DBA/2Jmice, compared with C57BL/6J and
A/J strains, which showed similar insulin responsiveness (Fig-
ure 2B). Insulin-stimulated suppression of hepatic glucose pro-
duction (HGP) was significantly blunted (p = 0.001) in DBA/2J
mice as compared with A/J mice (Figure 2C), and C57BL/6J
mice displayed an intermediate phenotype for HGP suppression
(Figure 2C).
We also performed ex vivo analysis of insulin action and
observed that the rate of insulin-stimulated 2-deoxyglucose up-
take into the soleus muscle was reduced by 93% for DBA/2J
compared to A/J (Figure S3A). Furthermore, insulin-stimulated
Akt phosphorylation (Figure S3B) and p85-activated IRS1
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(Figure S3C) were decreased in DBA/2J mice, indicating
decreased muscle insulin sensitivity. Consistent with findings
of diminished glucose disposal in DBA/2J mice, total Glut4 pro-
tein was significantly reduced in quadriceps muscle from DBA/
2J compared with A/J mice (Figure S3D). In addition to per-
forming detailed physiologic and molecular assessment of in-
sulin sensitivity, we performed metabolic chamber monitoring
of A/J and DBA/2J mice to identify potential variations in en-
ergy expenditure from the two strains of mice. Both activity
(Figure S3E) and respiratory exchange rate (RER) (Figure S3F)
were similar between A/J and DBA/2J mice after 8 weeks of
HF/HS feeding; thus, energy expenditure cannot explain the
differences in IR between A/J and DBA/2J. Furthermore,
DBA/2J and A/J did not show any overt difference in body fat
percentage after 8 weeks of HF/HS feeding, suggesting that
obesity is not the cause of the variation in IR between these
two strains (Figure S3G). Taken together, the euglycemic-hy-
perinsulinemic clamp and molecular data support our HOMA-
IR assessment (Figure 1A).
Contribution of Sex Hormones to Variation in IR
We observed a large difference between males and females in
HOMA-IR after 8 weeks of HF/HS feeding, whereby females
generally remained more insulin sensitive versus their male
counterparts (Figure 1A). To understand this difference and
assess the importance of gonadally derived hormones among
strains of mice, we designed experiments to test the influence
of testosterone and estrogen in males and females, respec-
tively. We examined three genetically unique strains of mice
(C3H/HeJ, C57BL/6J, DBA/2J) that have different levels of
HOMA-IR.
In male mice on a chow diet, gonadectomy improved
HOMA-IR in strain C57BL/6J mice, but not in C3H/HeJ or
DBA/2J mice, indicating that testosterone exhibits gene-sex
interactions (Figure 2D). Similarly, in male mice fed a HF/HS
diet for 8 weeks, gonadectomy improved HOMA-IR only in
strain C57BL/6J (Figure 2D). In female mice, ovariec-
tomy increased HOMA-IR in all three strains on both chow
and HF/HS diet, demonstrating that estrogens provide
A
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Figure 1. Large Genetic Variation in Insulin Resistance among Male and Female Inbred Strains of Mice
(A) HOMA-IR in male (black) and female (red) mice after 8 weeks of HF/HS feeding.
(B–E) Correlation of HOMA-IR with body fat percentage (B), mesenteric fat mass (C), gonadal fat mass (D), and retroperitoneal fat mass (E) in male mice,
regression line (red). r, biweight midcorrelation; p, p value.
(F–I) Correlation of HOMA-IR with body fat percentage (F), mesenteric fat mass (G), gonadal fat mass (H), and retroperitoneal fat mass (I) in female mice,
regression line (red). r, biweight midcorrelation; p, p value. Error bars represent SEM.
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insulin-sensitizing effects in female mice. Both gonade-
ctomy and ovariectomy influenced body fat percentage, but
the results depended on strain and diet (Figures S4A and
S4B). Overall our studies indicate that estrogens improve IR
and may partially explain why we observed lower HOMA-IR
among female mice in all the strains of mice we analyzed
(Figure 1A). This finding is consistent with published re-
ports showing that ovariectomy in rodents and primates ac-
celerates development of IR (Kumagai et al., 1993; Wagner
et al., 1998). Furthermore, our studies indicate that test-
osterone influences development of IR in a strain-specific
manner.
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Figure 2. Molecular Analysis of IR among Strains of Mice and Role of Gonadal Hormones in Development of IR
(A) Glucose infusion rate (GIR) required to maintain euglycemia during euglycemic hyperinsulinemic clamp studies in A/J, C57BL/6J, and DBA/2J mice after
8 weeks of HF/HS feeding.
(B) Skeletal muscle insulin sensitivity represented by the insulin-stimulated glucose disposal rate (IS-GDR) during euglycemic hyperinsulinemic clamp studies in
A/J, C57BL/6J, and DBA/2J mice after 8 weeks of HF/HS feeding.
(C) Hepatic glucose production (HGP suppression percentage) during euglycemic hyperinsulinemic clamp studies in A/J, C57BL/6J, and DBA/2J mice after
8 weeks of HF/HS feeding.
(D) HOMA-IR in male C3H/HeJ, C57BL/6J, and DBA/2J mice after gonadectomy, sham, or control, and being maintained on a chow or HF/HS diet for 8 weeks.
(E) HOMA-IR in female C3H/HeJ, C57BL/6J, and DBA/2J mice after ovariectomy, sham, or control, and being maintained on a chow or HF/HS diet for 8 weeks.
Asterisk (*) indicates significance of p < 0.05. Error bars represent SEM.
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Genome-wide Association Mapping for IR
and Related Traits
To identify genetic loci and understand the genetic architecture
of IR, we performed GWAS analysis with 200,000 high-quality
single-nucleotide polymorphisms (SNPs) spaced throughout the
genome. To account for population structure among themicewe
used a linear mixedmodel.We used a genome-wide significance
threshold of 3.46 3 106, which we have determined through
permutation and modeling (Bennett et al., 2010). Due to the
strong variation between males and females that is dependent
on genetic background (Figures 1A, S1, and S2), we performed
association separately between males and females. In males,
we identified two genome-wide significant loci associated with
HOMA-IR on chromosomes 1 and 9 (Figure 3A; Table 1). The
peak SNP for chromosome 1 (rs32316569; p = 5.563 107) con-
tains 109 genes within linkage disequilibrium (LD), and we and
others have reported associations with metabolic traits within
this region (Chen et al., 2008; Machleder et al., 1997; Parks
et al., 2013). One potential causal gene within this locus is apoli-
poprotein AII (ApoA2), which has previously been reported to
exacerbate IR when overexpressed in transgenic mice (Castel-
lani et al., 2008). The peak SNP at the chromosome 9 locus
(rs36804270; p = 9.633 107) contains 16 genes within LD. In fe-
male mice we did not identify any genome-wide significant loci
associated with HOMA-IR (Figure 3B).
In addition to HOMA-IR we also performed GWASs with
related glycemic indices including plasma insulin and glucose
levels. In males, two genome-wide significant loci, on chromo-
somes 1 and 15, respectively (Figure S5A; Table 1), were associ-
ated with plasma insulin levels. The peak SNP for chromosome 1
(rs31614030; p = 4.66 3 106) is the same locus identified with
HOMA-IR. The chromosome 15 locus (rs32269281; p = 2.85 3
106) has 11 genes within LD. In females we identified one
genome-wide significant locus associated with plasma insulin
levels, on chromosome 4 (rs27896920; p = 4.463 106), contain-
ing 13 genes within LD (Figure S5B; Table 1). In our data HOMA-
IR and plasma insulin levels have a correlation of r = 0.56 inmales
and r = 0.45 in females, which may explain why we observed
similar loci in male, but not female, mice. Plasma glucose levels
had one genome-wide significant locus in both males and
Female HOMA-IRMale HOMA-IR
A B
Female Mesenteric Fat Mass/Bodyweight
Female Plasma TriglyceridesMale Plasma Triglycerides
Male Mesenteric Fat Mass/Bodyweight
D
F
C
E
X X
X X
X X
Figure 3. Widespread Genetic Control of IR and Related Traits
(A and B) Manhattan plot showing the significance (log10 of p) of all SNPs and HOMA-IR after 8 weeks of HF/HS feeding in male mice (A) and female mice (B).
(C and D) Manhattan plot showing the significance (log10 of p) of all SNPs andmesenteric fat mass normalized to body weight after 8 weeks of HF/HS feeding in
male mice (C) and female mice (D).
(E and F) Manhattan plot showing the significance (log10 of p) of all SNPs and plasma triglyceride levels after 8 weeks of HF/HS feeding in male mice (E) and
female mice (F).
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females (Figures S5C and S5D; Table 1). Themale-specific chro-
mosome 7 locus (rs3680765; p = 1.523 107) contains 13 genes
within LD, while the female-specific chromosome 11 locus
(rs27001755; p = 3.33 3 107) contains 8 genes within LD.
We performed association with common traits associated with
IR, including central obesity and plasma triglyceride levels (Pou-
liot et al., 1992). Using themesenteric fat pad normalized to body
weight we identified one genome-wide significant locus in males
and four significant loci in females (Figures 3C and 3D; Table 1).
Both males and females contained a strong locus on chromo-
some 7 (rs32000744; males p = 2.71 3 106, females p =
8.733 107), suggesting this locus may harbor a genetic variant
that influences central obesity irrespective of sex. Female mice
contained threemore genome-wide significant loci, two on chro-
mosomes 15 (rs32263766; p = 8.533 107 and rs37298722; p =
3.88 3 106) and one on chromosome 17 (rs33115366; p =
4.143 106). The chromosome 15 locus (rs37298722) in females
contained one gene within LD, Dnahc5, a dynein protein that is
associated with the microtubule-associated motor protein com-
plex. Sequence analysis identified multiple non-synonymous
coding variants among inbred strains of mice for Dnahc5 (Keane
et al., 2011). Mutations inDnahc5 have been associated with pri-
mary ciliary dyskinesia type 3 (Hornef et al., 2006). While Dnahc5
has not been directly linked to obesity, influencing ciliary function
has been shown to affect obesity traits (Davenport et al., 2007).
Elevations in plasma triglycerides are commonly associated
with IR and central obesity (Pouliot et al., 1992). We measured
plasma triglyceride levels among the mice included in our study
and did not observe a significant correlation with obesity (data
not shown). Plasma triglycerides varied from 7 to 160 mg/dl in
male mice and from 8 to 168 mg/dl in female mice (Figure S2B).
We identified a genome-wide significant locus for plasma triglyc-
eride levels on chromosome 7 in both males (rs31371723; p =
4.64 3 107) and females (rs33903345; p = 7.94 3 1012) (Fig-
ures 3E and 3F; Table 1). In females the locus on chromosome
7 associated with both central obesity and plasma levels of
triglycerides in female mice (Figures 3D and 3F; Table 1).
Male mice also shared a genome-wide significant locus at the
chromosome 7 locus for central obesity (Figures 3C and 3E; Ta-
ble 1). The co-mapping of central obesity and plasma triglycer-
ides suggests that a common genetic variant influences both
of these metabolic traits. In females there was also a significant
locus on chromosome 17 (rs33060525; p = 4.18 3 106) (Fig-
ure 3E; Table 1). In total, we were able to identify 15 genome-
wide significant loci associated with IR and related traits among
males and females (Table 1).
Systems Genetics Analysis of Global Gene Expression
Our GWAS analysis allowed us to identify five loci associated
with IR and plasma insulin and glucose levels among males
and females. To further refine these loci and identify high-confi-
dence candidate genes we measured global gene expression
with microarrays in the livers and adipose tissue of HF/HS-fed
male mice. Performing GWASs with gene expression data
allowed us to identify genes that were regulated locally (cis
eQTL) versus distally (trans eQTL) and ultimately pinpoint genes
that have strong genetic variation. In the liver of male HF/HS-fed
mice we identified 4,599 cis-regulated genes and 6,244 trans-
regulated genes, while in adipose tissue we identified 4,440
cis-regulated genes and 6,812 trans-regulated genes.
Focusing on the two peak SNPs on chromosomes 1 and 9
significantly associated with HOMA-IR in male mice, we investi-
gated genes regulated in cis by rs3231659 and rs36804270,
respectively. We identified six genes in adipose tissue and three
genes in the liver that showed evidence of significant genetic
regulation by rs3231659 on chromosome 1 (Table S2). For
peak rs36804270 on chromosome 9 we identified 14 genes in
adipose tissue and 15 genes in the liver that showed evidence
of significant genetic regulation (Table S2). For the chromosome
9 locus (Figures 4A and 4B) only one gene, Acad11, has both
a significant cis eQTL (3.33 104) regulated by rs36804270 (Fig-
ures 4C, 4D, and S6E) and is significantly correlated with HOMA-
IR (Figure 4E). Acad11 is an acyl-CoA dehydrogenase that can
metabolize long chain fatty acids and generate energy through
beta oxidation (He et al., 2011), and our studies implicate
Acad11 as a strong candidate for future studies in IR.
Table 1. Genome-wide Significant Loci for Insulin Resistance and Related Traits
Trait Sex Chr. Peak SNP Position (Mb) p Value MAF LD No. of Genes
HOMA-IR male 1 rs32316569 175768939 5.22E07 0.35 175.5–177.4 109
HOMA-IR male 9 rs36804270 104875641 1.84E06 0.36 103.9–105.7 16
Insulin male 15 rs32269281 21154862 2.85E06 0.47 19.0–26.9 11
Insulin male 1 rs31614030 173308737 4.66E06 0.28 172.1–177.4 109
Insulin female 4 rs27896920 71287837 4.46E06 0.33 70.1–75.8 13
Glucose male 7 rs3680765 49397123 1.52E07 0.30 49.0–55.3 13
Glucose female 11 rs27001755 112944793 3.33E07 0.28 112.2–114.6 8
Plasma triglycerides male 7 rs31371723 76638409 4.64E07 0.28 74.2–79.6 20
Plasma triglycerides female 7 rs33903345 65789990 7.94E12 0.20 59.0–67.5 38
Plasma triglycerides female 17 rs33060525 35595846 4.18E06 0.38 35.0–35.9 61
Mesenteric fat/body weight male 7 rs32000744 67559538 2.71E06 0.45 59.0–67.5 38
Mesenteric fat/body weight female 15 rs32263766 91948444 8.53E07 0.29 90.9–95.2 22
Mesenteric fat/body weight female 7 rs32000744 67559538 8.73E07 0.48 59.0–67.5 38
Mesenteric fat/body weight female 15 rs37298722 28527523 3.88E06 0.30 28.3–29.6 1
Mesenteric fat/body weight female 17 rs33115366 47452733 4.14E06 0.40 47.4–47.6 6
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In addition to the identification of loci regulating gene expres-
sion we correlated liver and adipose gene expression with
HOMA-IR. A number of genes within the top 50 most correlated
genes have been previously implicated in the pathology of IR (Ta-
bles S3 and S4). Specifically, the most significantly correlated
gene in the liver was Igfbp2, which has a strong negative corre-
lation with IR (r = 0.65; p = 2.05 3 1023) (Figure S6A). Consis-
tent with this finding, previous experimental studies in mice have
shown that Igfbp2 is an important anti-diabetic gene in the liver
(Hedbacker et al., 2010). In both liver and adipose tissue expres-
sion of Irs2 was strongly negatively correlated with HOMA-IR
(Figures S6B and S6C). Irs2 is a key insulin signaling molecule,
and consistent with this observation genetic deletion of Irs2
causes IR and diabetes (Withers et al., 1998). Additionally, in
adipose tissue Cebpb was strongly positively correlated with
HOMA-IR (Figure S6D). Cebpb is a transcription factor respon-
sible for diverse biological responses, and consistent with our re-
sults mice lacking Cebpb have greater insulin sensitivity (Wang
et al., 2000).
Integration of Plasma Metabolites
Metabolomic-based approaches have been utilized with great
success to identify groups of metabolites that correlate with
development of diabetes and related traits (Cheng et al., 2012;
Wang et al., 2011). To identify metabolites associated with IR
we used a targeted mass spectrometry approach to measure
amino acids, amines, and other polar metabolites in the plasma
of male mice after 8 weeks of HF/HS feeding. Correlation anal-
ysis with the 47 metabolites identified xanthosine and ADMA/
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Figure 4. Systems Genetics Analysis of
HOMA-IR
(A) Locus plot for genome-wide significant associa-
tion with HOMA-IR in male mice at chromosome 9
with approximate LD block (shaded in gray), peak
SNP (red), and Acad11 gene position (green).
(B) HOMA-IR distribution based on genotype distri-
bution at peak SNP associated with HOMA-IR on
chromosome 9 (rs36804270). Box and whisker plot
depicting mean and distribution.
(C) Acad11 adipose expression based on genotype
distribution at peak SNP associated with HOMA-IR
on chromosome 9 (rs36804270). Box and whisker
plot depicting mean and distribution.
(D) Gonadal expression QTL (eQTL) for Acad11
showing significance (log10 of p) of all SNPs on
chromosome 9 with indicated position of gene (red
arrow) of cis eQTL.
(E) Correlation of Acad11 expression in gonadal ad-
ipose tissue with HOMA-IR, regression line (red). r,
biweight midcorrelation; p, p value.
SDMA (asymmetric dimethylarginine/sym-
metric dimethylarginine) to have the stron-
gest correlations to an IR trait, plasma
glucose levels (Figure 5A). Xanthosine is
an intermediate metabolite of purine meta-
bolism that is commonly studied in the
pathology of gout, a condition commonly
observed in obesity and consumption of
diet rich in fat (Choi et al., 2005). Levels of
ADMA/SDMA have been observed to correlate with hyperglyce-
mia in humans, and our studies confirm this relationship (Palomo
et al., 2011).
To identify genetic loci regulating specific metabolites we per-
formed GWASs with individual metabolites. In total we identified
23 genome-wide significant loci for 10 metabolites (Table S5).
Some metabolite loci contained genes with a known biological
link to the specific metabolite. For example, phosphocholine
has one genome-wide significant locus at chromosome 2
(rs27441517; p = 5.04 3 108) containing four phospholipase
genes (Pla2g4b, Pla2g4d, Pla2g4e, and Pla2g4e), which are
known to act predominantly on phosphocholine-containing lipid
species to cleave the sn2 fatty acid (Figure 5B). Additionally,
plasma levels of 20-deoxyadenosine, an adenosine derivative,
mapped to chromosome 12 (rs37817859; p = 2.88 3 106)
(Figure 5C). The peak SNP at this locus is within the poly(A) po-
lymerase alpha, Papola, which is a key enzyme mediating poly-
adenylation during mRNA processing.
We also investigated if any metabolites showed significant
regulation by peak SNPs associated with HOMA-IR and related
traits. The peak SNP on chromosome 9 (rs36804270) associated
with HOMA-IR showed a significant (p = 6.73 104) association
with plasma levels of arginine (Table S2). Human studies have
observed connections between arginine and IR, and our data
further confirm this connection (McLaughlin et al., 2006). Some
studies have even found beneficial effects of L-arginine supple-
mentation on insulin sensitivity (Piatti et al., 2001). Additionally,
there was evidence that the peak SNP on chromosome 9 was
also associated with plasma niacinamide levels (Table S2). The
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chromosome 1 peak SNP (rs32316569) was also associatedwith
plasma levels of glycerol and taurine (Table S2). Overall, the inte-
gration of plasmametabolite data allowed for identification of re-
lationships between IR traits and the identification of genetic loci
that contribute to metabolite regulation.
Identification and Validation of Agpat5 as an
Effector of IR
The recombinant inbred (RI) strains that are part of the HMDP
panel (BXA, AXB, BXH, CXB, and BXD) provide significant power
for genome-wide association analysis (Bennett et al., 2010). The
BXD subset is by far the largest of these RI panels, and the BXD
set alone provides sufficient power for genome-wide mapping.
We have routinely examined this subset of mice for association,
since if a genetic variation exists between the strains C57BL/6J
and DBA/2J, but not between the other RI panels, we would lose
power by including the other RI sets within the HMDP. One of the
significant loci we identified for plasma insulin levels in this anal-
ysis of the BXD RI strains is on chromosome 8 (rs13479627; p =
7.33 3 107) (Figures 6A and 6B).
Within the chromosome 8 locus, Agpat5 (1-acylglycerol-3-
phosphate O-acyltransferase 5) was identified as a high-confi-
dence candidate gene. Our gene expression data identified
Agpat5 as having a strong cis eQTL in both liver and adipose
data sets, indicating there is local regulation of Agpat5 expres-
sion (Figures 6C and 6D). Furthermore, Agpat5 is the only gene
significantly regulated by the peak SNP, rs13479627 (Figures
6E and S6F). To test if Agpat5 is a gene associated with plasma
insulin levels and IR we used antisense oligonucleotides (ASOs)
to silence Agpat5 expression in vivo. Using specific ASOs
against Agpat5, we were able to knock down Agpat5 expression
by more than 70% in both the liver and adipose tissue (Figures
S7A and S7B). To determine if Agpat5 inhibition would improve
IR we fed C57BL/6J mice a high-fat diet for 12 weeks and then
treated with Agpat5 ASO or control ASO for 8 weeks. After
8 weeks of treatment with Agpat5 ASO mice had reduced
plasma insulin levels (Figure S7C). To determine IR, we per-
formed a glucose tolerance test in mice and found that mice
treated with Agpat5 ASO were able to clear glucose at a higher
rate than control-treated mice (Figure 6F).
In addition to studies in mice, we also performed studies in
rats fed a high-fructose diet for 12 weeks and then treated with
Agpat5 ASO or control ASO for 8 weeks. Consistent with the
mice data, Agpat5 ASO silenced expression in both liver and ad-
ipose (Figures S7D and S7E) in rats. Rats treated with Agpat5
ASO were able to clear glucose significantly more efficiently
than control-treated rats (Figure 6E), and plasma insulin was
also reduced (Figure S7F).
A
B
C
Figure 5. Systems Genetics Analysis of Plasma Metabolites
(A) Correlation of plasma metabolites with HOMA-IR, plasma glucose, and plasma insulin levels in male mice.
(B) Manhattan plot showing the significance (log10 of p) of all SNPs and plasma phosphocholine levels after 8 weeks of HF/HS feeding in male mice.
(C) Manhattan plot showing the significance (log10 of p) of all SNPs and plasma 50-deoxyadenosine levels after 8 weeks of HF/HS feeding in male mice.
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Agpat5 is a lipid acyltransferase gene that is important in the
conversion of lysophosphatidic acid to phosphatidic acid, and
biochemical studies indicate that Agpat5 is localized to the mito-
chondria (Prasad et al., 2011). Altogether our data identify
Agpat5 as a gene associated with plasma insulin levels and IR,
and our studies validate across two model organisms (mice
and rats) that inhibiting Agpat5 can significantly improve glucose
tolerance after high-fat or high-fructose feeding, respectively.
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Figure 6. Identification and Validation of Agpat5
(A) Manhattan plot showing the significance (log10 of p) of all SNPs and plasma insulin levels after 8 weeks of HF/HS feeding in male BXD RI strains. Candidate
gene for genome-wide significant loci are indicated above genome-wide significant loci.
(B) Plasma insulin levels based on genotype distribution at peak SNP associated with plasma insulin levels on chromosome 9 (rs36804270). Box and whisker plot
depicting mean and distribution.
(C) Liver expression QTL (eQTL) for Agpat5 showing significance (log10 of p) of all SNPs on chromosome 8 with indicated position of gene (red arrow) reflective
of cis eQTL.
(D) Gonadal adipose eQTL for Agpat5 showing significance (log10 of p) of all SNPs on chromosome 8 with indicated position of gene (red arrow) reflective of
cis eQTL.
(E) Agpat5 adipose expression based on genotype distribution at peak SNP associated with plasma insulin levels on chromosome 9 (rs36804270). Box and
whisker plot depicting mean and distribution.
(F) IP-GTT in C57BL/6J mice fed a high-fat diet for 12 weeks and treated with control ASO or Agpat5 ASO for 8 weeks.
(G) IP-GTT in rats fed a high-fructose diet for 12 weeks and treated with control ASO or Agpat5 ASO for 8 weeks. Asterisk (*) indicates significance of p < 0.05.
Error bars represent SEM.
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DISCUSSION
The genetic basis of IR has proved difficult to dissect in humans
due to themany confounding factors that can influence its devel-
opment. Using a mouse population in which environmental fac-
tors can be carefully controlled, we show that common mouse
strains exhibit striking variation in the development of IR when
fed a HF/HS diet for 8 weeks. We confirmed this variation in IR
using euglycemic hyperinsulinemic clamp studies as well as
detailed biochemical studies in strains A/J, C57BL/6J, and
DBA/2J mice. Our GWAS results identified three genome-wide
significant loci associated with HOMA-IR, one of these in the
subset of mice including only the BXD RI strains, and more
than a dozen significant loci associated with related traits,
such as plasma insulin, glucose, triglyceride, and central obesity,
among male and female strains. Using a systems genetics
approach we were able to integrate both global gene expression
data from liver and adipose tissues, as well as plasma metabo-
lomics data. Integration of gene expression allowed us to identify
high-confidence candidate genes for HOMA-IR loci and to iden-
tify genes highly correlated with HOMA-IR. Integrating metabo-
lomics data we were able to perform GWASs and in some cases
pinpoint known genes within the metabolite pathway as well as
identify a relationship between IR and plasma arginine levels.
Finally, we identified and validatedAgpat5 as a gene contributing
to IR.
Males and females differ dramatically in IR, and the genetic
basis of this difference has yet to be explored in detail. Our study
examines sex differences in IR across a broad set of genetic
backgrounds in mice. We observed large sex-biased variation
in HOMA-IR and other traits, including plasma insulin, glucose,
and central obesity. In some strains HOMA-IR was more than
10-fold greater in males, whereas in other strains, males and fe-
males were identical. This provides clear evidence for gene-by-
sex interactions. Our GWAS results failed to identify common
loci associated with HOMA-IR between males and females.
This is strikingly different from other traits such as food con-
sumption, where the loci observed are nearly identical between
sexes (B.W.P. and A.J.L., unpublished data). Taken together,
our findings demonstrate that unique genetic variants in males
and females contribute to IR. We investigated the influence of
gonadal hormones in males and females in three unique strains
of mice and showed that estrogen contributes to insulin sensi-
tivity in females, and testosterone exacerbates IR in C57BL/6J
mice, but not other strains we tested. In addition to gonadal hor-
mones, sex chromosomes may also contribute to the varied ge-
netic architecture in males and females (Chen et al., 2012).
Detailed analysis of the differences between males and females
would provide insights into the mechanisms that contribute to
this difference in genetic architecture.
An important result from our study is the identification of three
genome-wide significant loci for IR. Our ability to detect variants
associated with HOMA-IR may be increased for a number of
reasons. First, feeding the mice a HF/HS diet promoted the
emergence of genomic variants associated with IR. Second,
our mice were maintained in a uniform environment, unlike hu-
mans, who have diverse environmental settings. Lastly, mice
might harbor stronger genetic variants influencing HOMA-IR. In
addition to the identification of genetic loci associated with
HOMA-IR and plasma insulin and glucose levels, we also identi-
fied loci associated with central obesity and plasma triglyceride
levels. Central obesity and plasma triglycerides are commonly
associated with IR, and in females we identified a locus on chro-
mosome 7 associated with both central obesity and plasma tri-
glyceride levels. Central obesity and plasma triglyceride levels
are not correlated in our data, and the co-mapping of these
two traits to the same locus suggests a common genetic variant
may contribute to both traits. A locus on chromosome 7 has pre-
viously been reported in an F2 cross between strains C57BL/6
and 129S6 to associate with plasma leptin levels; however, our
locus is proximal to this locus (Almind et al., 2003).
Using a systems genetics approach we integrated gene
expression data to identify loci controlling gene expression in
both liver and adipose tissue. We prioritized genes based on
cis eQTL and coding sequence variants. For both genome-
wide significant loci associated with HOMA-IR we were able to
identify multiple genes significantly associated with the peak
SNP, which indicates local genetic variation. For the chromo-
some 9 locus, one gene, Acad11, is a high-confidence gene
based on the cis eQTL for this gene and the strong negative cor-
relation with HOMA-IR in adipose tissue. Acad11 is a gene
involved in beta oxidation and plays a role in metabolizing fatty
acids to provide energy. In addition to a role in white adipose tis-
sue, Acad11 is highly expressed in brown adipose tissue, and
our preliminary studies indicated that Acad11 gene expression
is increased after high-fat feeding in brown adipose tissue
(B.W.P. and A.J.L., unpublished data). Brown adipose tissue is
metabolically active, and studies in mice indicate that brown ad-
ipose is important in regulating insulin sensitivity and develop-
ment of IR (Stanford et al., 2013), thus, based upon our findings,
further functional studies on Acad11 are warranted.
In addition to integrating gene expression data into our study,
we also measured metabolites in the plasma using a targeted
mass spectrometry-based approach.We identified both correla-
tions and > 20 genome-wide significant loci associated with spe-
cific metabolites. Using GWASs we were able to pinpoint genes
involved in their metabolism of specific metabolites, thereby
demonstrating the power of our approach to uncover biological
pathways and integrate across biological scales. The branched-
chain amino acids isoleucine, leucine, valine, tyrosine, and
phenylalanine are often elevated in individuals with IR, and these
amino acids have been used as predictive indices of diabetes
development (Newgard et al., 2009; Wang et al., 2011). In
contrast, our analyses did not find evidence for this relationship.
This may be due to the limited duration of HF/HS feeding
compared with longer feeding required to develop metabolic
consequences typically associated with increased branched-
chain amino acids in the plasma. Integrating metabolite data
we were able to show that plasma arginine levels are associated
with a genome-wide significant locus on chromosome 9 associ-
ated with HOMA-IR.
Our work provides a resource to identify genes and pathways
involved in the development of IR. To validate the resource we
identified Agpat5 as a high-confidence candidate gene within a
locus associated with plasma insulin levels and HOMA-IR in
the BXD RI population. We showed that silencing Agpat5
expression improves insulin sensitivity in both mice and rats. In
addition to Agpat5, we identify Acad11 as a high-confidence
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candidate gene associated with IR. Our study provides a view
of gene-diet interactions and the genetic architecture of IR
and related traits in a population of common inbred strains
of mice.
EXPERIMENTAL PROCEDURES
Animals
All mice were obtained from The Jackson Laboratory and were bred at Univer-
sity of California, Los Angeles to generate mice used in this study. Mice were
maintained on a chow diet (Ralston Purina Company) until 8 weeks of age
when they were given a HF/HS diet (Research Diets D12266B) with the
following composition: 16.8% kcal protein, 51.4% kcal carbohydrate, 31.8%
kcal fat. A complete list of the strains included in our study is included in Table
S1. The animal protocol for the study was approved by the Institutional Animal
Care and Use Committee (IACUC) at University of California, Los Angeles.
Gonadectomy and Ovariectomy
Male and female mouse strains C57BL/6J, C3H/HeJ, and DBA/2J were pur-
chased from The Jackson Laboratory (Bar Harbor). Mice were either main-
tained on a chow diet (Ralston Purina Company) or placed on an HF/HS diet
(Research Diets D12266B) at 8 weeks of age until 16 weeks of age. At 6 weeks
of age the mice were gonadectomized under isoflurane anesthesia. Scrotal re-
gions of male mice were bilaterally incised, testes removed, and the incisions
closed with wound clips. Ovaries of female mice were removed through an
incision just below the rib cage. There were four mice per group. The muscle
layer was sutured, and the incision closed with wound clips. In sham-operated
control mice, incisions were made and closed as described above. The
gonads were briefly manipulated, but remained intact.
Body Composition and Visceral Adipose Analyses
Animals were measured for total body fat mass and lean mass by MRI using
Bruker Minispec. To assess size of the three major adipose tissue depots
within the visceral cavity, themesenteric, gonadal, and retroperitoneal adipose
tissues were carefully dissected from each mouse and weighed.
Plasma Insulin, Glucose, and Triglycerides
Retro-orbital blood was collected under isoflurane anesthesia after 4 hr of fast-
ing. Plasma insulin, glucose, and triglycerides were determined as previously
described (Castellani et al., 2008). The HOMA-IR was calculated using the
equation [(Glucose 3 Insulin)/405].
Hyperinsulinemic-Euglycemic Clamp Studies and Ex Vivo Soleus
Muscle Strip Glucose Uptake
Themethods are described in detail in Supplemental Experimental Procedures.
Association Analysis
Genome-wide association of clinical traits, adipose, and liver expression data
was performed using FaST-LMM, which uses a linear mixed model to correct
for population structure (Lippert et al., 2011). For detailed methods see Sup-
plemental Experimental Procedures.
RNA Isolation and Expression Profiling
Total RNA from adipose (211 females, 228 males) and liver (206 females, 227
males) tissue was hybridized to Affymetrix HT_MG-430A arrays and scanned
using standard Affymetrix protocols. To reduce the chances of spurious asso-
ciation results, RMA normalization was performed after removing all individual
probes with SNPs and all probesets containing eight or more SNP-containing
probes, which resulted in 22,416 remaining probesets. To determine the accu-
racy of our microarray data we tested by qPCR the expression of Aacs and
found a r = 0.7 correlation between qPCR and microarray.
Metabolomics
Metabolic profiling of amino acids, biogenic amines, and other polar plasma
metabolites was analyzed by LC-MS as previously described (Roberts et al.,
2012; Wang et al., 2011). Metabolite concentrations were determined using
the standard addition method.
Agpat5 Validation Studies
C57BL/6J male mice were fed a high-fat diet (Harlan Teklad 06414) for
12 weeks and randomized based on body weight and plasma triglyceride
levels. Mice were administered control ASOs or Agpat5 ASO (Isis Pharmaceu-
ticals) for 8 weeks. ASOs were administered weekly at 25 mg/kg. Following
8 weeks of ASO treatment, plasma was obtained for insulin quantification.
Intraperitoneal glucose tolerance tests (IP-GTTs) were performed on 6-hr-
fasted mice with 1g/kg glucose as previously described (Hevener et al.,
2007). Male Sprague-Dawley rats were fed a high-fructose diet (Harlan Teklad
89247) for 12 weeks and randomized based on plasma insulin and glucose.
Rats were then administered subcutaneously control ASOs or Agpat5 ASOs
(25 mg/kg/week) for 8 weeks. Following 8 weeks of ASO treatment IP-GTT
was performed.
Statistics
Unless otherwise noted values presented are expressed as means ± SEM.
Statistical analyses were performed using one- and two-way ANOVA using
R statistical programming. Significance was set at p < 0.05.
ACCESSION NUMBERS
The NCBI GEO accession number for the microarray data reported in this
paper is GSE64770.
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Supplemental Information includes seven figures, five tables, and Supple-
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